\-\ Texto\\:\\ \ \(0\)\
\-\ overweight\\ white\\ man\\.\\ \\ no\\ masses\\ on\\ abdominal\\ exam\\.\ \(0\)\
\-\ esophageal\\ stent\\,\\ expectant\\ management\ \(0\)\
\-\ upper\\ gi\\ fluoroscopy\\ \\-\\ shows\\ a\\ polypoid\\,\\ ulcerated\\ distal\\ esophageal\\ mass\\,\\ with\\ inflammatory\\ changes\\ vs\\.\\ superficial\\ spread\\ into\\ the\\ adjacent\\ gastric\\ fundus\\.\ \(0\)\
\-\ ct\\ shows\\ multiple\\ rounded\\ lesions\\ in\\ the\\ liver\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ esophagus\ \(0\)\
\-\ esophageal\\ adenocarcinoma\\ metastatic\\ to\\ liver\ \(0\)\
\-\ esophageal\\ squamous\\ carcinoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 64\\ yo\\ gentleman\\ who\\ presents\\ with\\ 6\\ months\\ of\\ dysphagia\\ to\\ solids\\.\\ \\ he\\ did\\ smoke\\,\\ but\\ quit\\ 20\\ yrs\\ ago\\.\\ \\ he\\ denies\\ more\\ than\\ social\\ drinking\\.\\ \\ admits\\ to\\ occasional\\ esophageal\\ reflux\\.\ \(0\)\
\-\ adenocarcinoma\\ is\\ increasing\\ in\\ frequency\\.\\ \\ dysphagia\\ should\\ be\\ evaluated\\ with\\ an\\ upper\\ gi\\,\\ which\\ is\\ an\\ easily\\ performed\\ test\\.\\ \\ \ \(0\)\
\-\ esophageal\\ carcinoma\\ spreads\\ fairly\\ quickly\\ as\\ the\\ esophagus\\ does\\ not\\ have\\ a\\ serosal\\ membrane\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophageal\\:\\ 0\\.49552729930508593\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.23700478450449727\ \(0\)\
\-\ dysphagia\\:\\ 0\\.17460379637826706\ \(0\)\
\-\ gi\\:\\ 0\\.1623888003090613\ \(0\)\
\-\ esophagus\\:\\ 0\\.15919939586959572\ \(0\)\
\-\ spreads\\:\\ 0\\.1545764905647214\ \(0\)\
\-\ liver\\:\\ 0\\.13335771308295596\ \(0\)\
\-\ expectant\\:\\ 0\\.13334905442555983\ \(0\)\
\-\ drinking\\:\\ 0\\.13334905442555983\ \(0\)\
\-\ serosal\\:\\ 0\\.13334905442555983\ \(0\)\
\-\ overweight\\:\\ 0\\.12730537754070428\ \(0\)\
\-\ smoke\\:\\ 0\\.1228597475139237\ \(0\)\
\-\ quit\\:\\ 0\\.1228597475139237\ \(0\)\
\-\ admits\\:\\ 0\\.1228597475139237\ \(0\)\
\-\ ulcerated\\:\\ 0\\.12160402533354564\ \(0\)\
\-\ gentleman\\:\\ 0\\.11831414967372342\ \(0\)\
\-\ solids\\:\\ 0\\.11642948743057321\ \(0\)\
\-\ carcinoma\\:\\ 0\\.1156323744591217\ \(0\)\
\-\ he\\:\\ 0\\.1144741351213341\ \(0\)\
\-\ polypoid\\:\\ 0\\.11394536556199264\ \(0\)\
\-\ quickly\\:\\ 0\\.11394536556199264\ \(0\)\
\-\ shows\\:\\ 0\\.11345925893622653\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.10926439154051025\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.10868994685998275\ \(0\)\
\-\ yrs\\:\\ 0\\.10759637419666468\ \(0\)\
\-\ metastatic\\:\\ 0\\.10602367954805038\ \(0\)\
\-\ upper\\:\\ 0\\.10330461275397564\ \(0\)\
\-\ fairly\\:\\ 0\\.10144712379130322\ \(0\)\
\-\ membrane\\:\\ 0\\.10144712379130322\ \(0\)\
\-\ fundus\\:\\ 0\\.10037658919438405\ \(0\)\
\-\ social\\:\\ 0\\.10037658919438405\ \(0\)\
\-\ stent\\:\\ 0\\.09751936244849606\ \(0\)\
\-\ easily\\:\\ 0\\.09666483708996476\ \(0\)\
\-\ superficial\\:\\ 0\\.0933913092319182\ \(0\)\
\-\ occasional\\:\\ 0\\.09316386292797979\ \(0\)\
\-\ frequency\\:\\ 0\\.09185979693384948\ \(0\)\
\-\ 64\\:\\ 0\\.09084485315977407\ \(0\)\
\-\ rounded\\:\\ 0\\.08795368990098769\ \(0\)\
\-\ squamous\\:\\ 0\\.08698516943054264\ \(0\)\
\-\ spread\\:\\ 0\\.08682899786211622\ \(0\)\
\-\ reflux\\:\\ 0\\.08371376188723652\ \(0\)\
\-\ evaluated\\:\\ 0\\.08258788321751433\ \(0\)\
\-\ gastric\\:\\ 0\\.0814188338359656\ \(0\)\
\-\ test\\:\\ 0\\.07861427522332422\ \(0\)\
\-\ denies\\:\\ 0\\.07795706560727485\ \(0\)\
\-\ the\\:\\ 0\\.07714674714631597\ \(0\)\
\-\ increasing\\:\\ 0\\.07612580247650017\ \(0\)\
\-\ an\\:\\ 0\\.07392305762569393\ \(0\)\
\-\ vs\\:\\ 0\\.07373964772001738\ \(0\)\
\-\ to\\:\\ 0\\.07249260496146995\ \(0\)\
\-\ management\\:\\ 0\\.07139644404003982\ \(0\)\
\-\ ago\\:\\ 0\\.07072225222686838\ \(0\)\
\-\ did\\:\\ 0\\.06933825922026617\ \(0\)\
\-\ does\\:\\ 0\\.06682144780560555\ \(0\)\
\-\ masses\\:\\ 0\\.06580261939769837\ \(0\)\
\-\ inflammatory\\:\\ 0\\.06535902089034519\ \(0\)\
\-\ white\\:\\ 0\\.06377192362568913\ \(0\)\
\-\ should\\:\\ 0\\.06306905577802147\ \(0\)\
\-\ adjacent\\:\\ 0\\.06265345089143003\ \(0\)\
\-\ 20\\:\\ 0\\.062357469650095344\ \(0\)\
\-\ yo\\:\\ 0\\.0603861641541109\ \(0\)\
\-\ changes\\:\\ 0\\.05841580227841895\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05756556564010502\ \(0\)\
\-\ performed\\:\\ 0\\.05718293174712292\ \(0\)\
\-\ with\\:\\ 0\\.05678027950611097\ \(0\)\
\-\ months\\:\\ 0\\.05626252345161388\ \(0\)\
\-\ distal\\:\\ 0\\.056160447870475146\ \(0\)\
\-\ lesions\\:\\ 0\\.05551153665080406\ \(0\)\
\-\ than\\:\\ 0\\.05479242611239666\ \(0\)\
\-\ who\\:\\ 0\\.05467548641274542\ \(0\)\
\-\ more\\:\\ 0\\.053075342016591906\ \(0\)\
\-\ is\\:\\ 0\\.05294066232275932\ \(0\)\
\-\ abdominal\\:\\ 0\\.052864586871408\ \(0\)\
\-\ into\\:\\ 0\\.05138149817770956\ \(0\)\
\-\ man\\:\\ 0\\.05117171559101881\ \(0\)\
\-\ exam\\:\\ 0\\.048657467106952575\ \(0\)\
\-\ have\\:\\ 0\\.04828575607310222\ \(0\)\
\-\ in\\:\\ 0\\.04809053100665796\ \(0\)\
\-\ but\\:\\ 0\\.04779731746418345\ \(0\)\
\-\ multiple\\:\\ 0\\.047277319223241125\ \(0\)\
\-\ presents\\:\\ 0\\.04649727854551586\ \(0\)\
\-\ which\\:\\ 0\\.04395115699112916\ \(0\)\
\-\ disease\\:\\ 0\\.04057341245107294\ \(0\)\
\-\ be\\:\\ 0\\.03921011039684176\ \(0\)\
\-\ as\\:\\ 0\\.038830774705359165\ \(0\)\
\-\ not\\:\\ 0\\.0381581078433858\ \(0\)\
\-\ of\\:\\ 0\\.037830915707619955\ \(0\)\
\-\ mass\\:\\ 0\\.03692060994431122\ \(0\)\
\-\ ct\\:\\ 0\\.03679844290302464\ \(0\)\
\-\ no\\:\\ 0\\.03143194064699617\ \(0\)\
\-\ on\\:\\ 0\\.02919224405470502\ \(0\)\
